Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Marks

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Hematology|March 22, 2021
Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologistKatrin Schmittlutz, Reinhard Marks
Springer Seminars in Immunopathology|June 2, 2006
Biologics in the prevention and treatment of graft rejectionReinhard Marks, Jürgen Finke
Blood|January 17, 2017
Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfallAnnette Schmitt-Graeff, Reinhard Marks
Haematologica|December 3, 2019
Teaming up for CAR-T cell therapyRalph Wäsch, Markus Munder, Reinhard Marks
Cancers|June 19, 2024
Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?Tim Strüßmann, Reinhard Marks, Ralph Wäsch
Plos One|November 15, 2014
Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiationSujit V Janardhan, Reinhard Marks, Thomas F Gajewski
Dermatologie (Heidelberg, Germany)|March 24, 2025
[Dermatological conditions requiring intensive care treatment]Christiane Marks, Eugen Widmeier, Reinhard Marks, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|February 13, 2025
[Dermatological conditions requiring intensive care treatment]Christiane Marks, Eugen Widmeier, Reinhard Marks, et al.
Annals of Hematology|September 28, 2004
Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategiesRobert Zeiser, Reinhard Marks, Hartmut Bertz, et al.
Future Oncology (London, England)|February 8, 2019
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced agePieternella J Lugtenburg, Alexander R Lyon, Reinhard Marks, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Hematology|March 22, 2021
Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologistKatrin Schmittlutz, Reinhard Marks
Springer Seminars in Immunopathology|June 2, 2006
Biologics in the prevention and treatment of graft rejectionReinhard Marks, Jürgen Finke
Blood|January 17, 2017
Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfallAnnette Schmitt-Graeff, Reinhard Marks
Haematologica|December 3, 2019
Teaming up for CAR-T cell therapyRalph Wäsch, Markus Munder, Reinhard Marks
Cancers|June 19, 2024
Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?Tim Strüßmann, Reinhard Marks, Ralph Wäsch
Plos One|November 15, 2014
Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiationSujit V Janardhan, Reinhard Marks, Thomas F Gajewski
Dermatologie (Heidelberg, Germany)|March 24, 2025
[Dermatological conditions requiring intensive care treatment]Christiane Marks, Eugen Widmeier, Reinhard Marks, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|February 13, 2025
[Dermatological conditions requiring intensive care treatment]Christiane Marks, Eugen Widmeier, Reinhard Marks, et al.
Annals of Hematology|September 28, 2004
Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategiesRobert Zeiser, Reinhard Marks, Hartmut Bertz, et al.
Future Oncology (London, England)|February 8, 2019
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced agePieternella J Lugtenburg, Alexander R Lyon, Reinhard Marks, et al.
Pageof 8